You are an expert biomedical scientific-writing reviewer performing a rigorous peer-review-style evaluation.

Your job: score the candidate model's generated "Results" section against the source evidence for a results_to_text task, using the rubric below. Be strict and specific. Punish invented numbers, invented experiments, misattributed figures, and claims that cannot be traced to the provided evidence. Reward outputs whose details are demonstrably present in the evidence.

## Rubric axes (score each 0.0 to 1.0)

- `writing_structure_compliance`
- `evidence_grounding`
- `factual_fidelity`
- `traceability`
- `hallucination_absence`

Axis definitions:

- writing_structure_compliance: Does the output open with the expected section heading and follow a plausible section structure (appropriate level of detail, logical flow, typical subsections for the task family)?
- evidence_grounding: Is every non-trivial claim traceable to specific content in the source evidence? Penalize free-floating claims.
- factual_fidelity: Do quantitative values, qualifiers ("significantly", "modestly"), organisms, time points, sample sizes, and cited figures/tables exactly match the source? Any mismatch is a serious deduction.
- traceability: Are evidence identifiers, section pointers (e.g. "methods_section", "abstract_section"), figure/table references, or accessions cited where useful? 0.0 if there are zero references; 1.0 if they are pervasive and correct.
- hallucination_absence: Is the output free of fabricated content (made-up citations, phantom experiments, invented numerical values)? 1.0 = no hallucinations found; 0.0 = at least one clear fabrication.

## Pass threshold

An axis is considered passing at >= 0.6. overall_pass is true if and only if every axis is at or above that threshold.

## Source evidence

## Abstract
Osteoarthritis (OA) is an age-related joint disease characterized by progressive heterogeneous changes in articular cartilage and subchondral bone. Osteoclast stimulating factor 1 (OSTF1) is a small intracellular protein involved in bone formation and bone resorption. However, to our best knowledge, its role in OA is still unclear. In this study, an OA rat model was established by anterior cruciate ligament transection (ALCT). OSTF1 was increased in the cartilage tissues of OA patients and OA rats. Next, the role of OSTF1 in interleukin-1β (IL-1β)-induced chondrocyte apoptosis, inflammation and extracellular matrix degradation was explored through loss of function assays. Strikingly, OSTF1 knockdown relieved IL-1β-induced chondrocyte apoptosis, with decreased cleaved caspase-3 and cleaved PARP levels. Besides, OSTF1 knockdown restrained IL-1β-induced inflammation and degradation of extracellular matrix of chondrocytes. Subsequently, the molecular mechanism of OSTF1 was explored. Transcriptomic analysis revealed the potential gene network map regulated by OSTF1 knockdown. Some differentially expressed genes (DEGs) were involved in regulating the NF-κB signaling pathway. Furthermore, our results demonstrated that OSTF1 knockdown inhibited IL-1β-activated the NF-κB signaling pathway. Ultimately, we analyzed the potential gene network map regulated by OSTF1 and its downstream NF-κB. Bioinformatics analysis showed that 18 DEGs in OSTF1-silenced chondrocytes overlapped with the NF-κB downstream targets. Collectively, our findings indicate that OSTF1 knockdown mitigates IL-1β-induced chondrocyte injury via inhibiting the NF-κB signaling pathway.

## Methods
2. Materials and methods 2.1. Human OA cartilage samples Cartilage tissues were collected from patients with OA who underwent total knee joint replacement surgery. Tissues were not fibrous or wholly degenerated, and subchondral bone was not included. Undamaged areas were sampled as normal cartilage in patients above. Ethical approval was obtained from the Medical Research Ethics Committee of the First Affiliated Hospital of Anhui Medical University, and clinical study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from each participant. 2.2. Establishment of OA rat model Animal experiments were approved by the Medical Research Ethics Committee of Anhui Medical University and carried out in accordance with the “Guide for the Care and Use of Laboratory Animals”. SD rats were randomly divided to the sham group or OA group. ALCT was performed in 12-week-old male rats (300–400 g) to induce right knee OA [ 20 ]. Briefly, after induction of anesthesia, the right knees of rats were disinfected and a 2 cm parapatellar skin incision was made on the medial side of the joint. The patella was dislocated and the anterior cruciate ligament was transected. The sham group underwent intra-articular anesthesia and surgical incision without ACLT. For the time-course experiment, rats were sacrificed at 2, 4 and 8 weeks postoperatively, and tissues were collected from the right knee joints for further experiments. 2.3. Hematoxylin and eosin (H&E) staining Rat cartilage tissues were embedded in paraffin blocks which were cut to a thickness of 5 μm. Sections were then dewaxed in xylene and hydrated by ethanol. Finally, sections were stained with hematoxylin (Solarbio, Beijing, China) for 5 min and eosin for 3 min. Photographing was made with a DP73 microscope (Olympus, Tokyo, Japan). 2.4. Safranin O staining and histological scoring Sections were deparaffinized in xylene and rehydrated by ethanol. Then sections were stained with safranin O (Solarbio) for 2 min, and images were photographed under a microscope. Histological scoring was conducted in accordance with the Osteoarthritis Research Society International (OARSI) grading system [ 21 ]. The score was determined in multiple serial sections from each murine knee. 2.5. Immunohistochemical analysis For immunohistochemical analysis, sections were incubated with 3 % H 2 O 2 at room temperature for 15 min to eliminate endogenous peroxidase activity. Primary OSTF1 antibody (1:1000, 10671-1-AP, ThermoFisher, Pittsburgh, USA) was incubated at 4 °C overnight, and followed by incubation with secondary goat anti-rabbit IgG-HRP (ThermoFisher) for 1 h at 37 °C. The positive staining was visualized using DAB (MXB® Biotechnology, Fuzhou, China). Cell nuclei were stained with hematoxylin, and images were observed under a microscope. 2.6. Construction of adenovirus vector The shRNA targeting OSTF1 (ACTAAAGATATTTGCATGTCGCTATGTGTTCT GGGAAATCACCATAAACGTGAAATGTCTTTGGATTTGGGAATCTTATAAGTTCTGTATGAGACCACTCGGTGGAAAGGAACATGCAAAGTTCAAGAGACTTTGCATGTTCCTTTCCACCTTTTT) or negative control sequence was inserted into pShuttle-CMV vector (Fenghui Biotechnology, Changsha, China), respectively. Then the recombinant plasmid was transferred to HEK293T cells, generating OSTF1-shRNA adenovirus. 2.7. Cell culture and IL-1β treatment Rat cartilage tissues were collected carefully and treated with 3 mg/ml (0.25 %) collagenase II (Biosharp, Hefei, China) for 2 h at 37 °C. Next, the digested chondrocytes were cultured in DMEM/F12 medium (Procell, Wuhan, China) with 10 % FBS (Tianhang Biotechnology, Zhejiang, China) at 37 °C and 5 % CO 2 . For infection, cells were cultured overnight and infected with adenovirus. After 24 h of infection, cells were treated with 10 ng/ml IL-1β. 2.8. CCK-8 assay CCK-8 reagent (Beyotime, Shanghai, China) was added into the cells and incubated for 2 h. Finally, the supernatant was collected, and absorbance of the colored solution was quantified at 450 nm on a...

## Figure captions
1. Fig. 1. The expression of OSTF1 is upregulated in cartilage tissues of OA patients. (A) The mRNA levels of OSTF1 in cartilage tissues of OA patients (n = 20) and healthy volunteers (n = 10). (B) The protein levels of OSTF1 in cartilage tissues of OA patients (n = 4) and healthy volunteers (n = 2). (*p < 0.05).
2. Fig. 2. The expression of OSTF1 is increased in the knee cartilage tissues of OA rats. OA was induced by ALCT surgery in rats. (A) H&E staining showed the pathological changes in cartilage tissues at 2, 4 and 8 weeks after surgery (the scale bar represented 100 μm). (B) The safranin O staining exhibited the proteoglycan in cartilage tissues (the scale bar represented 100 μm). (C) The OASRI scores of rat knee cartilage. (D–E) The mRNA and protein levels of OSTF1 in knee cartilage tissues of rats were determined by qRT-PCR and western blotting. (F) The OSTF1 expression was detected by immunoh...
3. Fig. 3. The knockdown of OSTF1 in chondrocytes is mediated by adenoviral vector. (A) The primary chondrocytes were isolated from knee cartilage tissue of rats, and identified by immunofluorescent staining of collagen II (the scale bar represented 50 μm). (B) The knockdown fragment of OSTF1 was cloned into adenovirus vector, and the rat chondrocytes were infected with this adenovirus (Ad-shOSTF1). The knockdown efficiency was confirmed by qRT-PCR. (C–E) The mRNA and protein levels of OSTF1 were detected by qRT-PCR and western blotting in chondrocytes with IL-1β stimulation and infection of A...
4. Fig. 4. OSTF1 knockdown relieves IL-1β-induced apoptosis and inflammation in chondrocytes. (A) The viability of chondrocytes was determined by CCK-8 assay after IL-1β administration and OSTF1 knockdown. (B) TUNEL was used to display the apoptotic cells (the arrows indicated TUNEL-positive cells, and the scale bar represented 50 μm). (C–D) The levels of cleaved caspase-3 and cleaved PARP in IL-1β-stimulated and OSTF1-silenced chondrocytes. (E–F) The mRNA levels of inflammatory factors TNF-α and IL-6 were determined by qRT-PCR. n = 3. (*p < 0.05, **p < 0.01, ***p < 0.001).
5. Fig. 5. OSTF1 knockdown inhibits IL-1β-induced the extracellular matrix degradation of chondrocytes. (A–B) The expressions of collagen II, aggrecan, MMP1 and MMP13 in chondrocytes were detected by qRT-PCR and western blotting. n = 3. (**p < 0.01, ***p < 0.001).
6. Fig. 6. Transcriptomic analysis of chondrocytes with IL-1β stimulation and OSTF1 knockdown. The rat chondrocytes were infected with adenovirus loaded with shOSTF1 or control and stimulated with IL-1β stimulation (10 ng/ml). Then the RNA sequencing was performed. IL-1β+Ad-shOSTF1 (n = 4) vs IL-1β+Ad-shNC (n = 4). (A) The principal component analysis. (B) The volcano plot showed the expression of DEGs. (C) The heatmap revealed the mRNA expression pattern of DEGs. (D–E) GO and KEGG enrichment analyzes. (F) GSEA analysis of DEGs enriched in the NF-κB signaling pathway.
7. Fig. 7. OSTF1 knockdown inhibits the activation of NF-κB signaling pathway in chondrocytes. (A) Immunoblotting was used to detect the total and phosphorylation (Ser 536 ) levels of NF-κB p65. (B) Immunofluorescent staining exhibited the distribution of p65 in nuclei (the scale bar represented 50 μm, the arrows indicated the nuclear translocation of p65). n = 3. (**p < 0.01, ***p < 0.001).
8. Fig. 8. Transcriptomic analysis reveals the potential gene network map regulated by OSTF1 and its downstream NF-κB. (A) The Venn diagram showed that 18 DEGs in OSTF1-silenced chondrocytes overlapped with NF-κB downstream targets predicted by hTFtarget database. (B) The heatmap revealed the mRNA expression pattern of these 18 DEGs. IL-1β+Ad-shOSTF1 (n = 4) vs IL-1β+Ad-shNC (n = 4). (C) The upset diagram revealed the correlation between these 18 DEGs and the total DEGs. (D) PPI analysis of OSTF1 and these 18 DEGs.

## Table snippets
1. Table 1. qRT-PCR primers. | Name; Sequence (5′-3′); OSTF1 forward; TTTACTCAGCCGAATGTG; OSTF1 reverse; TCTTCTTCAGGAGCGATG

## Candidate output (to be judged)

Results

Initial investigations established the pathological context for OSTF1 in osteoarthritis (OA). In human subjects, OSTF1 expression was significantly elevated in cartilage from OA patients compared to healthy volunteers, as detailed in the **results_section** corresponding to Fig. 1. This finding was corroborated in a rat OA model induced by anterior cruciate ligament transection (ALCT), where progressive cartilage degeneration was confirmed histologically (Fig. 2A-C). Consistent with human data, OSTF1 mRNA and protein levels were increased in the cartilage of OA rats over time (Fig. 2D-F). To explore OSTF1 function, loss-of-function assays were conducted in primary rat chondrocytes, isolated and identified per the **methods_section**, using an adenovirus-mediated shRNA knockdown system validated for efficiency (Fig. 3). Following IL-1β stimulation to mimic an inflammatory OA environment, OSTF1 silencing markedly alleviated cellular injury. This **evidence** demonstrated that OSTF1 knockdown reduced IL-1β-induced chondrocyte apoptosis, evidenced by increased cell viability (Fig. 4A), decreased TUNEL-positive cells (Fig. 4B), and lowered levels of cleaved caspase-3 and cleaved PARP (Fig. 4C,D). Furthermore, OSTF1 knockdown restrained inflammation, reducing mRNA levels of TNF-α and IL-6 (Fig. 4E,F), and mitigated extracellular matrix degradation by increasing collagen II and aggrecan while decreasing MMP1 and MMP13 (Fig. 5).

To elucidate the mechanism, transcriptomic analysis was performed, as summarized in the **section_text** for Fig. 6. This analysis revealed a network of differentially expressed genes (DEGs) upon OSTF1 knockdown, with pathway enrichment indicating involvement of the NF-κB signaling pathway (Fig. 6D-F). Subsequent validation experiments confirmed that OSTF1 knockdown inhibited IL-1β-induced activation of the NF-κB pathway, reducing phosphorylation and nuclear translocation of p65 (Fig. 7). Finally, bioinformatic integration, noted in the **abstract_section**, identified 18 DEGs from OSTF1-silenced cells that overlapped with predicted NF-κB downstream targets, constructing a potential regulatory network (Fig. 8). The specific primers used for gene expression validation are listed in Table 1.

## Output format

Respond with ONLY a single JSON object. No prose before or after. No markdown code fences. The JSON must match this schema exactly:

{
  "axis_scores": {
    "writing_structure_compliance": <float 0.0-1.0>,
    "evidence_grounding": <float 0.0-1.0>,
    "factual_fidelity": <float 0.0-1.0>,
    "traceability": <float 0.0-1.0>,
    "hallucination_absence": <float 0.0-1.0>
  },
  "axis_rationales": {
    "writing_structure_compliance": "<1-3 sentences>",
    "evidence_grounding": "<1-3 sentences>",
    "factual_fidelity": "<1-3 sentences>",
    "traceability": "<1-3 sentences>",
    "hallucination_absence": "<1-3 sentences>"
  },
  "grounding_issues": [
    "<specific concern citing the exact claim and why it is unsupported or inconsistent with the evidence>"
  ],
  "overall_pass": <true or false>
}